Delmer A - Search Results

1

Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over a 16-year period.

Baudard M, Beauchamp-Nicoud A, Delmer A, Rio B, Blanc C, Zittoun R, Marie JP. Baudard M, et al. Among authors: delmer a. Leukemia. 1999 Oct;13(10):1481-90. doi: 10.1038/sj.leu.2401544. Leukemia. 1999. PMID: 10516746 Clinical Trial.

2

Multivariate analysis of prognostic factors in acute myeloid leukemia: value of clonogenic leukemic cell properties.

Delmer A, Marie JP, Thevenin D, Cadiou M, Viguié F, Zittoun R. Delmer A, et al. J Clin Oncol. 1989 Jun;7(6):738-46. doi: 10.1200/JCO.1989.7.6.738. J Clin Oncol. 1989. PMID: 2715804

3

Prognostic value of clonogenic assay for induction and duration of complete remission in acute myelogenous leukemia.

Marie JP, Zittoun R, Delmer A, Thevenin D, Suberville AM. Marie JP, et al. Among authors: delmer a. Leukemia. 1987 Feb;1(2):121-6. Leukemia. 1987. PMID: 3478535

4

Evaluation of carboplatin as a single agent in highly refractory acute myeloid leukemia.

Delmer A, Bauduer F, Vekhoff A, Rio B, Cymbalista F, Delmas-Marsalet B, Blanc CM, Cadiou M, Broca M, Renoux M, et al. Delmer A, et al. Leuk Lymphoma. 1994 Oct;15(3-4):311-5. doi: 10.3109/10428199409049729. Leuk Lymphoma. 1994. PMID: 7866280 Clinical Trial.

5

Expression of resistance genes in acute leukemia.

Zhou DC, Hoang-Ngoc L, Delmer A, Faussat AM, Russo D, Zittoun R, Marie JP. Zhou DC, et al. Among authors: delmer a. Leuk Lymphoma. 1994;13 Suppl 1:27-30. doi: 10.3109/10428199409052669. Leuk Lymphoma. 1994. PMID: 8075575

6

Cyclosporin A as a modifier agent in the salvage treatment of acute leukemia (AL).

Marie JP, Bastie JN, Coloma F, Faussat Suberville AM, Delmer A, Rio B, Delmas-Marsalet B, Leroux G, Casassus P, Baumelou E, et al. Marie JP, et al. Among authors: delmer a. Leukemia. 1993 Jun;7(6):821-4. Leukemia. 1993. PMID: 8099134 Clinical Trial.

7

Treatment of chronic myelogenous leukemia in blast crisis and in accelerated phase with high- or intermediate-dose cytosine arabinoside and amsacrine.

Bauduer F, Delmer A, Blanc MC, Delmas-Marsalet B, Cadiou M, Rio B, Marie JP, Zittoun R. Bauduer F, et al. Among authors: delmer a. Leuk Lymphoma. 1993 Jun;10(3):195-200. doi: 10.3109/10428199309145883. Leuk Lymphoma. 1993. PMID: 8220118 Review.

8

In vitro effect of rGM-CSF on proliferation and maturation of leukemic cells from patients with acute myelogenous leukemia.

Faussat-Suberville AM, Marie JP, Delmer A, Cadiou M, Zittoun R. Faussat-Suberville AM, et al. Among authors: delmer a. Leuk Lymphoma. 1993 Sep;11(1-2):99-104. doi: 10.3109/10428199309054735. Leuk Lymphoma. 1993. PMID: 8220160

9

Treatment of relapsing and refractory adult acute myeloid leukemia according to in vitro clonogenic leukemic cell drug sensitivity.

Delmer A, Marie JP, Thevenin D, Suberville AM, Zittoun R. Delmer A, et al. Leuk Lymphoma. 1993 May;10(1-2):67-71. doi: 10.3109/10428199309147358. Leuk Lymphoma. 1993. PMID: 8374525

10

Multidrug resistance gene expression in acute myeloid leukemia: major prognosis significance for in vivo drug resistance to induction treatment.

Hunault M, Zhou D, Delmer A, Ramond S, Viguié F, Cadiou M, Perrot JY, Levy V, Rio B, Cymbalista F, Zittoun R, Marie JP. Hunault M, et al. Among authors: delmer a. Ann Hematol. 1997 Feb;74(2):65-71. doi: 10.1007/s002770050259. Ann Hematol. 1997. PMID: 9063375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters